NCT01840319 - Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030) | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Survival Status at Day 30 After the Last Intake

Trial Locations (21)

13385

Pfizer Investigational Site, Marseille

13915

Pfizer Investigational Site, Marseille

25030

Pfizer Investigational Site, Besançon

33000

Pfizer Investigational Site, Bordeaux

33076

Pfizer Investigational Site, Bordeaux

34295

Pfizer Investigational Site, Montpellier

35033

Pfizer Investigational Site, Rennes

38700

Pfizer Investigational Site, La Tronche

42055

Pfizer Investigational Site, Saint-Etienne

44093

Pfizer Investigational Site, Nantes

57530

Pfizer Investigational Site, Ars-Laquenexy

63003

Pfizer Investigational Site, Clermont-Ferrand

67200

Pfizer Investigational Site, Strasbourg

75877

Pfizer Investigational Site, Paris

78157

Pfizer Investigational Site, Le Chesnay

80054

Pfizer Investigational Site, Amiens

94275

Pfizer Investigational Site, Le Kremlin-Bicêtre

95100

Pfizer Investigational Site, Argenteuil

06006

Pfizer Investigational Site, Nice

Unknown

Pfizer Investigational Site, Rouen

Pfizer Investigational Site, Toulouse